The Effects Of The Coverage Gap On Drug Spending: A Closer Look At Medicare Part D
The Effects Of The Coverage Gap On Drug Spending: A Closer Look At Medicare Part D
复制标题
DOI：
10.1377/hlthaff.28.2.w317
复制
发表时间：
2009-03-01
期刊：
影响因子：
9.7
通讯作者：
Lave, Judith R.
中科院分区：
文献类型：
--
作者：
Zhang, Yuting;Donohue, Julie Marie;Lave, Judith R.
我们计算了两组医疗保险受益人的处方药使用情况：没有保险缺口的雇主组，以及没有保险缺口或一些仿制药保险的个人D部分组。在那些有雇主保险的人中，40%的人达到了甜甜圈洞，而没有这种保险的人只有25%。总的来说，5%的人通过甜甜圈洞达到了灾难性的覆盖水平。那些在甜甜圈洞中没有覆盖的人减少了14%的吸毒；那些有一般保险的人减少了3%的使用。在“甜甜圈洞”中，共同支付0- 10美元的仿制药的覆盖最多可以通过初始共同保险增加6 - 9个百分点来提供资金。[卫生事务28，no. 1][2] (2009): w317-w325(2009年2月3日在线发布；10.1377/hlthaff.28.2.w317)]
We calculated prescription drug usage in two groups of Medicare beneficiaries: employer group with no coverage gap, and individual Part D group with no coverage or some generic drug coverage in the coverage gap. Among those with employer coverage, 40 percent reached the doughnut hole, compared with 25 percent of those without such coverage. Overall, 5 percent went through the doughnut hole to reach the catastrophic coverage level. Those lacking coverage in the doughnut hole reduced their drug use by 14 percent; those with generic coverage reduced their use by 3 percent. Coverage of generic drugs with a $0-$10 copayment in the doughnut hole could be financed by, at most, a six-to-nine-percentage-point increase in initial coinsurance. [Health Affairs 28, no. 2 (2009): w317-w325 (published online 3 February 2009; 10.1377/hlthaff.28.2.w317)]